Every Form 4 that Magnera Corporation (MAGN) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow MAGN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MAGN filings page.
RICKERTSEN CARL J reported acquisition or exercise transactions in this Form 4 filing.
Magnera Corp director Carl J. Rickertsen received a grant of 12,998 restricted stock units (RSUs), representing the right to receive an equal number of shares of common stock. The RSUs were awarded at a price of $0.00 per unit as a 2026 director grant.
According to the terms, this grant vests in full and all restrictions lapse one year from the grant date on March 9, 2027. The RSUs have no value until all restrictions lapse on the final vesting date, so their actual benefit depends on future vesting and the company’s share price at that time.
Magnera Corp reported that director Salmon Tom received a grant of 12,998 Restricted Stock Units on the company’s common stock, par value $.01 per share. The grant is classified as a derivative award acquisition with no cash exercise price.
According to the disclosure, these 2026 director RSUs vest in full and all restrictions lapse one year from the grant date. The filing shows 12,998 RSUs outstanding following the transaction, and notes that the units have no value until all restrictions lapse on the final vesting date.
Magnera Corp director Samantha J. Marnick received a grant of 12,998 Restricted Stock Units (RSUs) on the reported grant date. These RSUs were acquired at a price of $0.00 per unit as a director equity award and are held as direct ownership.
According to the footnotes, this 2026 director grant vests in full and all restrictions lapse one year from the grant date. The RSUs have no value until all restrictions lapse on the final vesting date, meaning their benefit depends on future vesting and the company’s share value at that time.
Hall Mary Dean reported acquisition or exercise transactions in this Form 4 filing.
Magnera Corp director Mary Dean Hall received a grant of 12,998 Restricted Stock Units. These RSUs were awarded at no cash cost and will vest in full, with all restrictions lapsing, one year from the grant date. According to the disclosure, the RSUs have no value until all restrictions lapse on the final vesting date.
Curless Michael S reported acquisition or exercise transactions in this Form 4 filing.
Magnera Corp director Michael S. Curless received a grant of 12,998 Restricted Stock Units (RSUs) on the reported date. These RSUs were awarded at a price of $0.00 per unit, reflecting an equity-based compensation award rather than an open-market purchase.
Following this grant, Curless beneficially owns 12,998 RSUs directly. According to the footnotes, this 2026 director grant vests in full and all restrictions lapse one year from the grant date, and the RSUs have no value until all restrictions lapse on the final vesting date.
Fogarty Kevin Michael reported acquisition or exercise transactions in this Form 4 filing.
Magnera Corp director Kevin Michael Fogarty was granted 12,998 restricted stock units (RSUs). The RSUs were awarded on the grant date with no cash price per unit. According to the award terms, this 2026 director grant vests in full and all restrictions lapse one year from the grant date.
Fahnemann Thomas reported acquisition or exercise transactions in this Form 4 filing.
Magnera Corp director Thomas Fahnemann received a grant of 12,998 Restricted Stock Units (RSUs) on March 9, 2026. The RSUs were awarded at a price of $0.00 per unit as a 2026 director grant.
According to the footnotes, these RSUs have no value until all restrictions lapse on the final vesting date. The 2026 director grant vests in full, and all restrictions lapse one year from the grant date, after which the units may deliver economic value to the director.
Brown Bruce reported acquisition or exercise transactions in this Form 4 filing.
Magnera Corp director Bruce Brown received a grant of 12,998 restricted stock units (RSUs). The RSUs were awarded on March 9, 2026 at a price of $0.00 per unit, reflecting a non-cash equity award rather than an open-market purchase.
According to the terms, this 2026 director grant vests in full and all restrictions lapse one year from the grant date. The footnotes state that these RSUs have no value until all restrictions lapse on the final vesting date, meaning their economic benefit depends on future vesting.
Magnera Corp executive Jill L. Urey reported equity award activity involving restricted stock units and common shares. On February 28, 2026, she exercised 1,571 restricted stock units, converting them into the same number of common shares at a reference price of $12.95 per share. A portion of these shares, 521 common shares, was withheld to cover tax obligations, leaving her with 5,134 common shares held directly after the transactions.
Magnera Corp executive Jill L. Urey, EVP, General Counsel and Corporate Secretary, reported routine equity compensation activity. On February 24, 2026, she exercised 205 restricted stock units, converting them into an equal number of common shares at $13.03 per share.
To cover tax obligations related to this vesting, 68 common shares were disposed of through a tax-withholding transaction, rather than an open-market sale. After these transactions, Urey directly owned 4,084 shares of Magnera common stock. The RSUs were part of a 2023 long-term incentive grant that vested in three annual installments.
Magnera Corp executive Maile Erin reported a new equity award of restricted stock units (RSUs). The Form 4 shows Erin, who serves as Executive Vice President and Chief Accounting Officer, holding 1,869 RSUs following a FY2026 grant tied to her appointment as Chief Accounting Officer.
The RSU grant vests in three equal installments: one-third on February 2, 2027, one-third on February 2, 2028, and one-third on February 2, 2029. All restrictions lapse and the award vests in full three years from the grant date, at which point the RSUs gain value.
Magnera Corp (MAGN) reported that director Bruce Brown received a grant of 5,871 restricted stock units (RSUs) on 11/14/2025. The RSUs were granted at a price of $0 and represent a prorated portion of the company’s Annual Director Award for the period between the 2024 RSU lapse reported on November 4, 2025 and the 2026 Annual Shareholder Meeting.
The filing explains that this 2025 prorated director award will vest in full one year from the grant date, on 11/14/2026. The RSUs have no value until all restrictions lapse on the final vesting date. Following this grant, Brown beneficially owns 5,871 derivative securities in the form of RSUs, held directly.
Magnera Corp reported a director equity grant on a Form 4 for board member Kevin Fogarty. On 11/14/2025, the director received 5,871 restricted stock units (RSUs) tied to Magnera common stock at a stated price of $0 per unit. The award is described as a 2025 Prorated Director Award, intended to align the director equity schedule with the timing of the Annual Shareholder Meeting. According to the filing, these RSUs have no value until all restrictions lapse, and this prorated grant is for the period between the 2024 RSU lapse reported on November 4, 2025 and the 2026 Annual Shareholder Meeting. The RSUs vest in full one year from the grant date, on 11/14/2026, and are held as direct ownership by the reporting person.
Magnera Corp director Michael Curless reported an equity grant on Form 4. On 11/14/2025 he received 5,871 restricted stock units (RSUs), each representing one share of Magnera common stock with a stated price of $0 for the derivative security. The award is described as a 2025 prorated director grant intended to align the director equity schedule with the company’s Annual Shareholder Meeting cycle.
These 5,871 RSUs are scheduled to vest in full one year from the grant date, on 11/14/2026, at which time the restrictions lapse and the units convert into common shares. Following this grant, Curless is shown as directly owning 5,871 derivative securities tied to Magnera common stock.
Magnera Corp reported a stock-based award to one of its directors, Thomas Fahnemann. On 11/14/2025, he received 5,871 restricted stock units (RSUs) of Magnera common stock at an exercise price of $0, reported as directly owned. The filing explains that this 2025 prorated director award is intended to align the director equity schedule with the company’s Annual Shareholders Meeting. The grant represents a prorated portion of the Annual Director Award covering the period between the 2024 RSU lapse reported on November 4, 2025 and the 2026 Annual Shareholder Meeting. The RSUs vest in full one year from the grant date, on 11/14/2026, at which time the restrictions lapse and the units can deliver value as shares of common stock.
Magnera Corp (MAGN) reported a Form 4 insider transaction for director Thomas Salmon involving a new grant of derivative securities in the form of restricted stock units (RSUs). On 11/14/2025, the director received 5,871 RSUs with an exercise price of $0, reflecting equity compensation rather than a cash purchase. These RSUs relate to Magnera common stock with par value $0.01 per share and vest in full one year from the grant date, on 11/14/2026. The company notes that RSUs have no value until all restrictions lapse on the final vesting date and explains that this 2025 prorated director award is intended to align the director equity schedule with the timing of the Annual Shareholder Meeting in 2026.
Magnera Corp director equity award reported
A Magnera Corp (MAGN) director filed a Form 4 disclosing a grant of 5,871 restricted stock units (RSUs) on 11/14/2025. The RSUs were granted at a price of $0 and are scheduled to vest in full one year from the grant date, on 11/14/2026, as part of a 2025 prorated director equity award.
The company explains that this grant is intended to align the director equity schedule with the timing of the Annual Shareholder Meeting. It represents a prorated value of the Annual Director Award for the period between the 2024 RSU lapse reported on November 4, 2025 and the 2026 Annual Shareholder Meeting, when directors who are reelected are expected to receive a full 2026 Annual Director Award.
Magnera Corp (MAGN) reported a routine equity award for one of its directors. On 11/14/2025, director Samantha Marnick received 5,871 restricted stock units (RSUs) that are settled in Magnera common stock with a par value of $0.01 per share. The RSUs were granted at a price of $0, meaning no cash payment is required by the director to receive the shares upon vesting.
The award is described as a 2025 Prorated Director Award, intended to align the director equity schedule with the timing of the Annual Shareholder Meeting. It represents a prorated value of the Annual Director Award for the period between the 2024 RSU lapse reported on November 4, 2025, and the 2026 Annual Shareholder Meeting. The RSUs vest in full one year from the grant date, on 11/14/2026, after which the restrictions lapse and the units convert into shares of common stock.
Magnera Corp (MAGN) reported that director Mary Hall received a grant of 5,871 restricted stock units (RSUs) on 11/14/2025. These RSUs have an exercise price of $0 and are scheduled to vest in full on 11/14/2026, one year from the grant date. Following this grant, she beneficially owns 5,871 derivative securities in the form of RSUs, held directly.
The company explains that this award is a 2025 Prorated Director Award, intended to align the director equity schedule with the timing of the Annual Shareholder Meeting. The grant represents a prorated value of the Annual Director Award for the period between the 2024 RSU lapse reported on November 4, 2025 and the 2026 Annual Shareholder Meeting, when directors who are reelected are expected to receive a full 2026 Annual Director Award.
Magnera Corp reported an equity award to its President & CEO, who also serves as a director, in a Form 4 filing. On 11/14/2025, the executive received 131,428 restricted stock units (RSUs) that are reported as derivative securities. The RSUs carry an exercise price of $0 and are held directly.
The FY2026 annual RSU grant vests in stages: one-third on 11/14/2026, one-third on 11/14/2027, and one-third on 11/14/2028. The company notes that the RSUs have no value until all restrictions lapse on the final vesting date, when shares of common stock become fully vested.
Magnera Corp (MAGN) reported an equity award to a senior executive. Executive Vice President, Chief Financial Officer and Treasurer James Till received a grant of 34,285 restricted stock units (RSUs) on 11/14/2025. These RSUs represent the FY2026 annual grant and are designed to convert into an equal number of shares of common stock once vesting conditions are met.
The award vests in three equal parts: one-third on 11/14/2026, one-third on 11/14/2027 and one-third on 11/14/2028. The filing notes that RSUs have no value until all restrictions lapse on the final vesting date, aligning the executive’s compensation with the company’s longer-term performance and share price over the three-year period.
Magnera Corp (MAGN) reported a new equity award for executive Tarun Manroa, who serves as EVP and COO. On 11/14/2025, Manroa received a grant of 34,285 restricted stock units (RSUs) tied to Magnera common stock at an exercise price of $0, meaning the units are issued without a cash exercise cost when they vest. The FY2026 annual RSU grant is structured so that one-third of the award vests on 11/14/2026, one-third on 11/14/2027, and the final third on 11/14/2028, with all restrictions lapsing three years from the grant date. The RSUs have no value to the executive until the vesting conditions and restrictions are fully satisfied.
Magnera Corp (MAGN) reported an equity award for executive officer Jill Urey, EVP, General Counsel and Corporate Secretary. On 11/14/2025, she was granted 14,285 restricted stock units (RSUs) with an exercise price of $0, reported as derivative securities beneficially owned directly. The FY2026 annual RSU grant is scheduled to vest in three equal installments on 11/14/2026, 11/14/2027 and 11/14/2028, and the RSUs have no value until all restrictions lapse on the final vesting date.
Magnera (MAGN) President & CEO Curt Begle reported an insider equity transaction. On 11/04/2025, he acquired 18,208 shares of common stock (code M) at $8.53, reflecting settlement of derivative equity. Following the transaction, he held 18,208 shares directly, plus indirect holdings of 3,083, 44,341, and 2,576 shares in family trusts.
His derivative holdings show 36,423 RSUs remaining. The FY2025 annual RSU grant vests one‑third on 11/04/2025, 11/04/2026, and 11/04/2027, with all restrictions lapsing three years from the grant date.
Magnera Corp (MAGN) reported an insider equity transaction by EVP, CFO & Treasurer James Till. On 11/04/2025, 4,749 shares of common stock were acquired upon RSU vesting (transaction code M) at a transaction price of $8.53. To cover taxes (code F), 2,023 shares were withheld at $8.53, leaving 2,726 shares directly owned after the transactions. Following these events, the reporting person also beneficially owned 9,502 RSUs. The FY2025 RSU grant vests one‑third on 11/04/2025, one‑third on 11/04/2026, and one‑third on 11/04/2027, with all restrictions lapsing three years from the grant date.
Magnera Corp (MAGN) — Form 4: The company’s EVP and COO reported equity activity on 11/04/2025. A total of 3,562 shares of common stock were acquired via the vesting and settlement of restricted stock units (transaction code M). To cover taxes, 1,580 shares were withheld (code F).
Following these transactions, the officer directly beneficially owned 2,015 common shares. Derivative holdings reported as of the same date include 7,126 RSUs. The FY2025 annual RSU grant vests one‑third on 11/04/2025, one‑third on 11/04/2026, and one‑third on 11/04/2027; restrictions lapse in full three years from the grant date.
Magnera Corp (MAGN) reported an insider equity transaction by its EVP, GC & Corp Sec on 11/04/2025. The officer acquired 1,583 shares of common stock through an RSU vest (code M) at $8.53 and had 441 shares withheld to satisfy tax obligations (code F) at $8.53.
Following these transactions, the officer beneficially owns 3,947 shares directly and 32 shares held in a 401(k) plan. The FY2025 RSU grant vests one‑third on 11/04/2025, 11/04/2026, and 11/04/2027; RSUs have no value until all restrictions lapse. Derivative holdings reported were 3,167 RSUs after the event.
Magnera Corp (MAGN) director Samantha Marnick reported the settlement of restricted stock units into 9,501 shares of common stock on 11/04/2025 (transaction code M). The filing lists a price of $8.53 for the common stock entry. Following the transaction, she directly owns 13,501 shares. Notes indicate the FY2025 director grant vests in full one year from the grant date, and RSUs have no value until restrictions lapse.
Magnera Corp (MAGN) reported an insider equity change. Director Thomas Fahnemann settled 7,125 restricted stock units into common stock on 11/04/2025 (transaction code M). The filing lists a $8.53 price for the acquired common shares. Following the transaction, he directly owns 83,622 shares.
The derivative line shows 7,125 RSUs converted into the same number of common shares at $0 for the derivative security, with no RSUs remaining after the event. The FY2025 director grant vests in full one year from the grant date.
Magnera Corp (MAGN) reported a Form 4 for a director reflecting the conversion of restricted stock units into common shares. On 11/04/2025, 9,501 shares of common stock were acquired (Code M) at a reported price of $8.53 per share, following the settlement of 9,501 RSUs at a derivative price of $0. After this transaction, the director directly owned 50,807 shares.
The filing notes that RSUs have no value until restrictions lapse and that the FY2025 Director grant vests in full and all restrictions lapse one year from the Grant Date.
Magnera Corp (MAGN) director Mary Hall reported acquiring 9,501 shares of common stock on 11/04/2025, reflected as a Code M transaction tied to the settlement of restricted stock units. The filing lists a common stock price of $8.53 for the non-derivative entry and $0 for the RSU conversion. Following the transaction, Hall beneficially owned 9,501 shares, held directly. The footnotes state the FY2025 director RSU grant vests in full and all restrictions lapse one year from the Grant Date.
Magnera Corp (MAGN) reported an insider equity change. On 11/04/2025, director Kevin Fogarty acquired 9,501 shares of common stock at $8.53, reflecting the vesting and settlement of restricted stock units. Following the transaction, his holdings were 22,314 shares held directly and 31,538 shares held indirectly through GBBH Family Limited Partnership.
Magnera Corp (MAGN) director Michael S. Curless reported acquiring 9,501 shares of common stock on 11/04/2025, shown with transaction code M. The common stock entry lists a price of $8.53, and the related RSU entry lists a price of $0 for the settlement.
Following the transaction, beneficial ownership is 9,501 shares held directly and 10,000 shares held indirectly by The Michael S Curless Trust. The filing notes the FY2025 Director grant vests in full and all restrictions lapse one year from the Grant Date.
Magnera Corp (MAGN) director Thomas E. Salmon reported acquiring 9,501 shares of common stock on 11/04/2025 through an RSU-related transaction coded M.
Following the transaction, he holds 9,501 shares directly and 35,289 shares indirectly via The Thomas E. Salmon Revocable Living Trust. The common stock line lists a price of $8.53, while the derivative RSU entry shows a price of $0 and a remaining balance of 0 derivative securities.
Magnera Corp (MAGN) director Bruce Brown reported an equity award settlement. On 11/04/2025, 9,501 shares of common stock were acquired via transaction code M, reflecting the conversion of restricted stock units. The Form 4 shows a share price entry of $8.53 on the non-derivative line.
Following the transaction, Brown beneficially owns 21,533 shares directly and 17,228 shares indirectly through the Bruce Brown Revocable Trust. The derivative table lists 9,501 RSUs converted into common stock at a derivative price of $0, with 0 RSUs remaining afterward. A footnote states the FY2025 Director grant vests in full and all restrictions lapse one year from the grant date.